![]() |
市場調查報告書
商品編碼
2016128
汽車空調市場報告:按技術、組件、車輛類型、銷售管道和地區分類(2026-2034 年)Automotive Climate Control Market Report by Technology, Component, Vehicle Type (Passenger Cars, Light Commercial Vehicle, Heavy Commercial Vehicle ), Distribution Channel, and Region 2026-2034 |
||||||
2025年全球汽車空調市場規模達118億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到183億美元,2026年至2034年的複合年成長率為4.86%。消費者對配備先進空調系統的車輛舒適性需求不斷成長,是推動市場成長的主要因素。
周邊動脈疾病(PAD)病例增加
人口老化、糖尿病和肥胖症的日益普遍導致全球周邊動脈疾病(PAD)病例數量激增,進而推動了動脈粥狀硬化斑塊切除術器械市場的成長。在美國,約有800萬至1200萬人患有PAD,其中50歲以上人口居多。在這800萬人中,有650萬人被診斷出患有PAD且年齡超過40歲。動脈動脈粥狀硬化斑塊切除術器械提供了一種微創方法來清除動脈斑塊,使其成為血管內治療的重要選擇。這些器械可以改善血流,緩解腿痛和疲勞等症狀。透過直接切除或汽化斑塊,這些器械可以恢復動脈通暢性,並顯著改善重度PAD患者的預後。
技術進步
動脈粥狀硬化斑塊切除術裝置的關鍵技術創新包括方向可控裝置的出現和高頻旋轉技術的引入,這些創新不斷提高裝置的有效性和安全性。例如,2020 年的一項研究表明,軌道動脈粥狀硬化斑塊切除術(一種拋光和去除斑塊的方法)可以有效開通閉塞的下肢動脈,成功率達 90%,而雷射動脈粥狀硬化斑塊切除術也能達到類似的血流改善效果,成功率為 76%。患者預後的改善以及外科醫生對這些裝置的日益青睞,推動了動脈粥狀硬化斑塊切除術裝置的發展。在一項納入 172 名患者的多中心研究中,Jetstream 裝置的使用證實了 99% 的裝置成功率,臨床評估的 6 個月和 12 個月重組率分別為 15% 和 26%。基於雙功能超音波成像的 1 年血管再阻塞率為 38%。
進入新興市場
主要主要企業正將目光投向醫療基礎設施正在發展、醫療支出不斷成長的新興經濟體,這為主要企業創造了新的市場機會。例如,巴西、俄羅斯、印度、中國和南非(金磚國家)等新興市場正日益影響全球醫療產品和服務的供需趨勢。預計2030年,巴西的醫療支出將佔GDP的8.4%,俄羅斯為5.2%,印度為3.5%,中國為5.9%,南非為10.4%。更先進的治療方法的出現,使得進入這些市場成為可能,也擴大了動脈粥狀硬化斑塊切除術設備的全球應用範圍。
The global automotive climate control market size reached USD 11.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 18.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.86% during 2026-2034. The growing demand for comfort in vehicles with advanced climate control systems is stimulating the market.
Rising Cases of Peripheral Artery Disease (PAD)
The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.
Technological Advancements
Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.
Expansion into Emerging Markets
Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.
The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels for 2026-2034. Our report has categorized the market based on product, application, and end user.
Directional Atherectomy Devices accounts for the majority of the market share
Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.
Peripheral Vascular accounts for the majority of the market share
The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.
Hospitals accounts for the majority of the market share
Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.
North America dominates the market
The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.
North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.